RECENT NEWS

Don Whitley Scientific (DWS) has launched a new gassing system for the rapid generation of multiple atmospheres (anaerobic, microaerobic and capnophilic) in gas jars.

OraSure Technologies a Pennsylvania, USA-based diagnostic firm and laboratory, has announced it is leading the Series B financing and has entered wide-ranging strategic distribution agreements with Sapphiros, a privately held consumer diagnostics portfolio company based in Boston, and certain of its related entities.

Epredia has launched US sales of SlideMate Laser, the newest addition to the company’s SlideMate portfolio of slide printers, used in pathology laboratories to identify and help track tissue samples.

In vitro diagnostics firm bioMérieux has announced the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimise antimicrobial prescriptions and monitor healthcare-associated infections.

The IBMS and AstraZeneca have published a paper outlining how to create the capacity the NHS needs for the future of cancer testing.

The Medicines and Healthcare products Regulatory Agency (MHRA), has published a regulatory ‘roadmap’, pointing the way ahead for new measures to support safe access to medical technology including AI and diagnostics.

Digital pathology solutions firm Paige has announced the release of a groundbreaking AI product developed from Paige’s Pathology Foundation Model, Virchow. The new application can detect cancer across more than 17 different tissue types including skin, lung, and the gastrointestinal tract, along with multiple rare tumour types and metastatic deposits.

HORIBA Medical has launched the new HELO 2.0 high-throughput automated haematology platform which is CE-IVDR approved. It has been designed in consultation with customers to further improve and cover all needs of high-throughput fully automated haematology.

Beckman Coulter Life Sciences has announced it has developed the first commercially available anti-TRBC2 conjugated antibody for flow cytometry, providing greater clarity to clinical researchers in the identification of T-cell neoplasms in areas including cancer research.

Cleanroom microbiology company Cherwell has announced it is joining the AnalytiChem group of companies. Cherwell will join seven other businesses within the group, located across Europe, North America and Australia.

The Department of Health and Social Care (DHSC) and the NHS have published an early market engagement to any organisations which are interested in the blood self-sampling/testing services for the build and private Beta phase of the digital NHS Health Check.

Following the publication of ISO 15189:2022 in December 2022, the first year of the three-year transition period is now complete and UKAS has issued an update on the transition process.

More than six million tests, scans and health checks have taken place at community diagnostic centres (CDCs) across the country, helping speed up diagnoses and treatments for NHS patients.

Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more diverse representation of the human genome. To more accurately account for this richer picture of human genomic variation, Thermo Fisher Scientific has launched the new Axiom PangenomiX Array, its largest and most ethnically diverse array to date, offering optimal genetic coverage for population scale disease studies and pharmacogenomic research.

Persistent regulatory ambiguity and NHS procurement processes mean the UK is at risk of missing out on the latest HealthTech innovations, the latest survey of the industry reveals.

Atom Scientific has announced a new distribution partnership with Falc Instruments for the UK, adding the Italian company’s laboratory equipment to its already extensive range.

Research into next-generation sequencing carried out at Brigham and Women’s Hospital suggests that revising current cancer care guidelines could allow approximately 6,000 more patients in the US to benefit from immunotherapy treatment each year.

The UK National Screening Committee (UK NSC) has endorsed the use of digital pathology as an alternative option to light microscopy for the review of cancer screening histopathology slides.

Record industrial action this week could see one of the most difficult starts to the year for health services across the country, the NHS has said.

Aiforia has entered into an exclusive licensing agreement with the Mayo Clinic in the United States to globally commercialise an AI model that improves prediction of colorectal cancer recurrence. The AI model - developed in collaboration with the Mayo Clinic - identifies important histological features of colorectal cancer and provides a recurrence prediction estimate useful for colorectal cancer treatment decisions.